References
- 1. Johnson, T.B. & Chernoff, L.H.J. (1912). Hydantoins: Synthesis of 5-Thiohydantoins [Nineteenth Paper]. Am. Chem. Soc. 34(9), 1208–1213. DOI: 10.1021/ja02210a011.
- 2. Seki, M., Kajiwara, D., Mizutani, H. & Minamiguchi, K. (2020). Analysis of novel enzalutamide-resistant cells: up-regulation of testis-specific Y-encoded protein gene promotes the expression of androgen receptor splicing variant 7 Transl. Cancer Res., 2020, 9(10), 6232–6245. DOI: 10.21037/tcr-20-1463.
- 3. Kyriakopoulos, C.E., Heath, E.I., Ferrari, A., Sperger, J.M., Singh, A., Perlman, S.B., Roth, A.R., Perk, T.G., Modelska, K. & Porcari, A., et al. (2020). Exploring Spatial-Temporal Changes in 18F-Sodium Fluoride PET/CT and Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide. J. Clin. Oncol. 38(31), 3662–3671. DOI: 10.1200/jco.20.00348.
- 4. Al-Salama, Z.T., (2018). Apalutamide: First Global Approval, Drugs, 78, 699–705. DOI: 10.1007/s40265-018-0900-z.
- 5. Dellis, A.E. & Papatsoris, A.G., (2018). Apalutamide: the established and emerging roles in the treatment of advanced prostate cancer. Expert. Opin. Investig. Drugs. 27(6), 553–559. DOI: 10.1080/13543784.2018.1484107.
- 6. Chong, J.T, Oh, W.K. & Liaw, B.C., (2018). Profile of apalutamide in the treatment of metastatic castration-resistant prostate cancer: evidence to dateOnco. Targets Ther. 11, 2141–2147. DOI: 10.2147/OTT.S147168.
- 7. Qamar, R., Saeed, A., Saeed, M. & Seo, S.Y., et al., (2018). Synthesis and enzyme inhibitory kinetics of some novel 3-(substituted benzoyl)-2-thioxoimidazolidin-4-one derivatives as α-glucosidase/α-amylase inhibitors. Med. Chem. Res. 27(5), 1528–1537. DOI: 10.1007/s00044-018-2170-4.
- 8. Desai, N.C., Vaghani, H.V., Karkar, T.J., Patel, B.Y. & Jadeja, K.A., (2017). Synthesis and antimicrobial studies of 1,2,3,4-tetrahydropyrimidine bearing imidazole analogues. Indian. J. Chem., 2017, 56B, 438–446. http://nopr.niscair.res.in/handle/123456789/41188.
- 9. Chérouvrier, J.R., Carreaux, F. & Bazureau, J.P., (2004). Reactivity of 2-Thiohydantoins Towards Various Electrophilic Reagents: Applications to the Synthesis of New 2-Ylidene-3,5-dihydro-4H-imidazol-4-ones. Molecules, 9(10), 867–875. DOI: 10.1002/chin.200306129.
- 10. Khodair, A.I., El-Subbagh, H.I., El-Emam, A.A. (1997). Synthesis of certain 5-substituted 2-thiohydantoin derivatives as potential cytotoxic and antiviral agents. Boll Chim Farm, 136, 561–567. Molecules 2006, 11 749.
- 11. Wang, Z.D., Sheikh, S.O., Zhang, Y. (2006). A Simple Synthesis of 2-Thiohydantoins. Molecules, 11, 739–750. DOI: 10.3390/11100739.
- 12. Takahashi, A., Matsuoka, H., Ozawa, Y. & Uda, Y. (1998). Antimutagenic Properties of 3,5-Disubstituted 2-Thiohydantoins. J. Agric. Food Chem., 46, 5037–5042. DOI:10.1021/jf980430x;
- 13. Froelich, E.; Fruehan, A.; Jackman, M.; Kirchner, F.K.; Alexander, E.J.; Archer, S. (1954). 5-Heptyl-2-Thiohydantion, A New Antitubercular Agent. J. Am. Chem. Soc. 1954, 76, 3099–3100. DOI: 10.1021/ja01640a088.
- 14. Al-Obaid, A.M.; El-Subbagh, H.I.; Khodair, A.I. & Elmazar, M.M. (1996). 5-substituted-2-thiohydantoin analogs as a novel class of antitumor agents. Anticancer Drugs, 7, 873. DOI: 10.1097/00001813-199611000-00009.
- 15. Lacroix, G., Bascou, J.-P., Perez, J. & Gadras, A.U.S. Pat. 6,018,052, 2000;
- 16. Lacroix, G., Bascou, J.P., Perez, J. & Gadras, A.U.S. Pat. 5,650,519, 1997;
- 17. Marton, J., Enisz, J., Hosztafi, S. & Timar, T.J. Agric. (1993). Preparation and Fungicidal Activity of 5-Substituted Hydantoins and Their 2-Thio Analogs. Food Chem., 41, 148–152. DOI: 10.1021/jf00025a031.
- 18. El-Barbary, A.A., Khodair, A.I., Pedersen, E.B. & Nielsen, C.J. (1994). S-Glucosylated hydantoins as new antiviral agents. Med. Chem., 37, 73–77. DOI: 10.1021/jm00027a009.
- 19. Tompkins, J.E. (1986). 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl N3-substituted 2-thiohydantoins as potential hypolipidemic agents. J. Med. Chem., 29, 855–589. DOI: 10.1021/jm00155a042.
- 20. Elwood, J.C., Richert, D.A. & Westerfeld, W.W. (1972). A comparison of hypolipidemic drugs in the prevention of an orotic acid fatty liver. Biochem. Pharmacol., 21, 1127–1132. DOI: 10.1016/0006-2952(72)90106-2.
- 21. Marx, J.V., Richert, D.A. & Westerfeld, W.W. (1970). Peripheral inhibition of thyroxine by thiohydantoins derived from amino acids. J. Med. Chem. 1970, 13, 1179–1181. DOI: 10.1021/jm00300a036.
- 22. Cheymol, J., Chabrier, P., Gay, Y. & Lavedan, J.P. (1951). [Inhibitory action on thyroid & molecular structure; 2. study of dithiocarbamates & their derivatives]. Arch. Int. Pharmacodyn. Ther. 1951, 88, 342–350.
- 23. Cheymol, J., Chabrier, P. & Gay, Y., Arch. (1951). [Antithyroid action and molecular structure. I. A study of thiohydantoins and their methyl esters]. Int. Pharmacodyn. Ther. 1951, 87, 321–323. DOI: 10.1042/bj0490125.
- 24. Archer, S., Unser, M.J. & Froelich, E. (1956). Some 5-(Oxoalkyl)-2-thiohydantoins and Their Derivatives. J. Am. Chem. Soc. 1956, 78, 6182. DOI: 10.1021/ja01604a064.
- 25. Curran, A.C.W.U.S. Pat. 3,984,430, 1976.
- 26. Nagpal, K.L.U.S. Pat. 4,473,393, 1984.
- 27. Mo, B., Li, J. & Liang, S. (1997). A method for preparation of amino acid thiohydantoins from free amino acids activated by acetyl chloride for development of protein C-terminal sequencing. Anal. Biochem., 249(1), 207–211. DOI: 10.1006/abio.1997.2156.
- 28. Cromwellt, L.D., Stark, G.R. (1969). Determination of the carboxyl termini of proteins with ammonium thiocyanate and acetic anhydride, with direct identification of the thiohydantoins. Biochemistry, 8, 4735–4740. DOI: 10.1021/bi00840a012,.
- 29. Nelson, J.V., Helber, M.J. & Brick, M.C.U.S. Pat. 5,695,917, 1997.
- 30. Ooi, T., Fukui, T., Kobayashi, M., Ueno, K., Kagami, K., Suzuki, M. & Nishino, K.U.S. Pat. 5,482,814, 1996.
- 31. Kandil, S.S., El-Hefnawy, G.B. & Baker, E.A. (2004). Thermal and spectral studies of 5-(phenylazo)-2-thiohydantoin and 5-(2- hydroxyphenylazo)-2-thiohydantoin complexes of cobalt(II), nickel(II) and copper(II). Thermochim. Acta, 414, 105–113. DOI: 10.1016/j.tca.2003.11.021.
- 32. Verma, S., Shrivastva, S. & Rani, P. (2012). Synthesis and spectroscopic studies of mixed ligand complexes of transition and inner transition metals with a substituted benzimidazole derivative and RNA bases. J. Chem. Pharm. Res., 2012, 4(1), 693–699.
- 33. Usharani, M., Akila, E. & Rajavel, R. (2012). Mixed ligand Schiff base complexes: synthesis, spectral characterization and antimicrobial activity. J. Chem. Pharm. Res., 2012, 4(1), 726–731.
- 34. Andrade, A., Namora, S.F. & Woisky, RG., (2000). Synthesis and characterization of a diruthenium–ibuprofenato complex: Comparing its anti-inflammatory activity with that of a copper(II)–ibuprofenato complex. J. Inorg. Biochem., 81, 23–27. DOI: 10.1016/S0162-0134(00)00106-9.
- 35. Ray, S.M. & Lahiri, S.C. (1990). Some reflections on “Future organizational trends of the ASA. J. Indian Chem. Soc., 67, 324–326. DOI: 10.1007/BF02691840.
- 36. Mathew, M., Palenik, G.J. & Clark, G.R. (1973). Crystal and molecular structures of chlorobis(acetone thiosemicarba-zone)nickel(II) chloride monohydrate and nitratobis(acetone thiosemicarbazone)nickel(II) nitrate monohydrate. Inorg. Chem., 12(2), 446–451. DOI: 10.1021/ic50120a041.
- 37. Arya, P., Singh, N., Gadi, R. & Chandra, S. (2010). Preparation, characterization and antiulcer activity of mixed ligand complex of Zn (II) with Famotidine and Glycine. J. Chem. Pharm. Res., 2(6), 253–257.
- 38. Hughes, M.N., Wilkinson, G., Gillard, R.D. & McCleverty, J.A. Comprehensive Coordination Chemistry, Vol 6, Pergamon Press, Oxford, 1987.
- 39. Raman, M., Muthuraj, P.V., Ravichandran, S. & Kulandaisamy, A., (2003). Synthesis, characterisation and electrochemical behaviour of Cu(II), Co(II), Ni(II) and Zn(II) complexes derived from acetylacetone andp-anisidine and their antimicrobial activity. Acad. Sci (Chem. Sci.), 2003, 115(3), 161–167. https://www.ias.ac.in/article/fulltext/jcsc/115/03/0161-0167.
- 40. Bauer, A.W., Kirby, W.M., Sherris, C. & Turck, M. (1966). Antibiotic Susceptibility Testing by a Standardized Single Disk Method. Amer. J. Clinical Pathology., 45, 493. DOI: 10.1093/ajcp/45.4_ts.493.
- 41. Pfaller, M.A., Burmeister, L., Bartlett, M.A. & Rinaldi, M.G., (1988). Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol. 26 (1988) 1437–1441.
- 42. National Committee for Clinical Laboratory Standards, Performance Vol. antimicrobial susceptibility of Flavobacteria, 1997.
- 43. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
- 44. NakamotoK, Infra-Red Spectra of Inorganic and Coordinated Compounds, John Wiley, New York (1963) p. 167.
- 45. Randall, H.M., Fowler, R.G., Fuson, N. & Dangl, J.R. Infrared Determination of Organic Structures. D. Van Nostrand, New York (1949).
- 46. Lever, A.B.P., Inorganic Electronic Spectroscopy, Elsevier, Amsterdam, 1968.
- 47. Lever, A.B.P. & Mantovani, E. (1971). Far-infrared and electronic spectra of some bis(ethylenediamine) and related complexes of copper(II) and the relevance of these data to tetragonal distortion and bond strengths. Inorg. Chem., 1971, 10, 817–826. DOI: 10.1021/ic50098a031.
- 48. Drago., R.S., Physical Methods in Inorganic Chemistry, Rein Hold Publishing Corporation, New York (1976) p. 395.